<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-1264</article-id>
      <article-id pub-id-type="doi">10.51847/rZRo3HIlbk</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Trust Is Not a Single Outcome in Pharmacy AI: A Realist Review of Acceptance, Reliance, and Refusal</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Nilsson</surname>
                <given-names>Peter</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Johansson</surname>
                <given-names>Eva</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Andersson</surname>
                <given-names>Lars</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Pharmacy AI and Trust Studies, Faculty of Pharmacy, Karolinska Institute, Stockholm, Sweden.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of AI Acceptance and Pharmacy Practice, Faculty of Pharmacy, Lund University, Lund, Sweden.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="peter.nilsson@ki.se">peter.nilsson@ki.se</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>30</day>
        <month>12</month>
        <year>2025</year>
      </pub-date>
      <volume>16</volume>
      <issue>4</issue>
      <fpage>43</fpage>
      <lpage>53</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Trust is frequently treated as a desirable implementation outcome for artificial intelligence (AI) in health care. In pharmacy practice, however, acceptance, observed reliance, calibrated verification, overreliance, refusal, disengagement, and workarounds are distinct outcomes that may arise through different mechanisms and have different safety implications. To explain what forms of trust-related behaviour occur around pharmacy-relevant AI, for whom, under which technical, clinical, professional, organizational, and governance conditions, and why. A RAMESES-aligned realist review used an initial programme theory, purposive iterative searching, relevance-and-rigour selection, context-mechanism-outcome extraction, design-appropriate appraisal, contradictory-case analysis, and abductive and retroductive reasoning. The search identified 54 retrieval records. Four duplicates were removed, leaving 50 unique records: 41 evidence records and nine methodology or reporting sources. Five evidence records were excluded during title and abstract screening. Of 36 reports sought, one was not retrieved; 35 full texts were assessed, nine were excluded, and 26 reports representing 26 studies entered the realist synthesis. No quantitative synthesis was conducted.

The evidence indicated that acceptance could occur without observed reliance. Appropriate reliance appeared conditional on task fit, credible validation, uncertainty communication, training, workflow integration, and retained professional control. Incorrect or authoritative AI advice could produce overreliance, whereas safety, privacy, accountability, equity, relational, or autonomy concerns could support justified refusal. Poor integration and responsibility ambiguity could contribute to disengagement or workarounds. Increasing trust is not an adequate implementation objective. Pharmacy AI should instead be evaluated for calibrated decision use, including verification, override, escalation, refusal, and non-use. The proposed programme theory is explanatory and requires prospective validation.</p>
      </abstract>
      <kwd-group>
                <kwd>Realist review</kwd>
                <kwd>Digital pharmacy</kwd>
                <kwd>Artificial intelligence</kwd>
                <kwd>Pharmacy practice</kwd>
                <kwd>Medication safety</kwd>
                <kwd>Evidence synthesis</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>